Biologics

Spinal Implants

Xtant Medical Announces Closing of First Tranche of $9.75 Million Private Investment

BELGRADE, Mont. , Aug. 31, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the closing of the first tranche of its previously announced private